Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9016334 | 0.83 | LMNA (0.53) | LMNARAB9AKDM4ESMN1; SMN2KMT2A | |
| SCHEMBL6361849 | 0.82 | LMNA (0.51) | LMNARAB9AKDM4ESMN1; SMN2CYP1A2 | |
| SCHEMBL333132 | 0.82 | LMNA (0.45) | LMNAL3MBTL1KDM4ESMN1; SMN2CYP1A2 | |
| SCHEMBL332859 | 0.82 | LMNA (0.54) | LMNAKDM4EMAPK1SMN1; SMN2KMT2A | |
| Ethyl Cartrizoate SCHEMBL2110540 | 0.81 | LMNA (0.47) | LMNAKDM4ESMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL370072 | 0.81 | LMNA (0.50) | LMNAL3MBTL1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL9016363 | 0.80 | LMNA (0.46) | LMNAKDM4EMAPK1SMN1; SMN2CYP1A2 | |
| SCHEMBL9413528 | 0.79 | LMNA (0.45) | LMNARAB9AL3MBTL1KDM4ESMN1; SMN2 | |
| SCHEMBL8814469 | 0.79 | LMNA (0.50) | LMNAKDM4EMAPK1SMN1; SMN2KMT2A | |
| SCHEMBL8752047 | 0.78 | LMNA (0.44) | LMNAKDM4ESMN1; SMN2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0601616-A1 | Iodinated aroyloxy carboxamides and contrast agents containing them | NanoSystems L.L.C. (US) | 1994-06-15 | — | — | EP | claimed |
| EP-2334393-A2 | METHODS OF PROCESSING MULTI-PHASIC DISPERSIONS | Baxter International Inc. (US) | 2011-06-22 | — | — | EP | disclosed |
| EP-2334396-A1 | METHODS OF PROCESSING MICROPARTICLES | Baxter International Inc. (US) | 2011-06-22 | — | — | EP | disclosed |
| EP-2334394-A1 | METHODS OF PROCESSING COMPOSITIONS CONTAINING MICROPARTICLES | Baxter International Inc. (US) | 2011-06-22 | — | — | EP | disclosed |
| EP-2317982-A2 | METHODS OF PROCESSING COMPOSITIONS CONTAINING MICROPARTICLES | Baxter International Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010022276-A9 | METHODS OF PROCESSING MULTI-PHASIC DISPERSIONS | BAXTER INTERNATIONAL INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2010022282-A1 | METHODS OF PROCESSING MICROPARTICLES | BAXTER INTERNATIONAL INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010022276-A2 | METHODS OF PROCESSING MULTI-PHASIC DISPERSIONS | BAXTER INTERNATIONAL INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010022293-A2 | METHODS OF PROCESSING COMPOSITIONS CONTAINING MICROPARTICLES | BAXTER INTERNATIONAL INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010022261-A1 | METHODS OF PROCESSING COMPOSITIONS CONTAINING MICROPARTICLES | BAXTER INTERNATIONAL INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-0601616-A1 | Iodinated aroyloxy carboxamides and contrast agents containing them | NanoSystems L.L.C. (US) | 1994-06-15 | — | — | EP | disclosed |
| US-5260478-A | Contrast agents in x-ray imaging compositions; medical diagnosis | STERLING WINTHROP INC. (US) | 1993-11-09 | — | — | US | disclosed |